Charles River Laboratories

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$1,002,549
$1,009,763
$1,026,117
$1,011,560
Gross Profit
284,244
349,021
335,462
320,194
EBITDA
-86,453
209,723
238,504
219,369
EBIT
-188,557
121,525
152,422
134,012
Net Income
-213,747
68,679
89,988
67,329
Net Change In Cash
1,002,549
1,009,763
1,026,117
1,011,560
Free Cash Flow
83,746
213,071
154,049
50,744
Cash
194,606
210,171
179,538
337,366
Basic Shares
51,138
51,583
51,846
51,842

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$4,049,989
$4,129,409
$3,976,060
$3,540,160
Gross Profit
1,331,821
1,502,556
1,462,651
1,334,638
EBITDA
581,143
1,032,118
1,035,860
854,291
EBIT
219,402
717,994
731,990
588,751
Net Income
22,203
474,624
486,226
390,982
Net Change In Cash
4,049,989
4,129,409
3,976,060
3,540,160
Cost of Revenue
-30,679
-4,535
Free Cash Flow
501,610
365,370
294,907
532,027
Cash
194,606
276,771
233,912
241,214
Basic Shares
51,628
51,451
51,301
51,425

Earnings Calls

Quarter EPS
2024-12-31
$2.66
2024-09-30
$2.59
2024-06-30
$2.80
2024-03-31
$2.27